Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.810
+0.020 (1.12%)
At close: Mar 28, 2025, 4:00 PM
1.821
+0.011 (0.60%)
After-hours: Mar 28, 2025, 7:53 PM EDT

Zentalis Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
67.43----
Upgrade
Gross Profit
67.43----
Upgrade
Selling, General & Admin
87.1259.454.5540.9433.89
Upgrade
Research & Development
167.77189.59172.73166.884.9
Upgrade
Operating Expenses
254.88248.99227.29207.74118.79
Upgrade
Operating Income
-187.46-248.99-227.29-207.74-118.79
Upgrade
Interest & Investment Income
12.279.462.261.311.24
Upgrade
Earnings From Equity Investments
--16.01-16.28-1.83-
Upgrade
EBT Excluding Unusual Items
-175.18-255.54-241.31-208.26-117.55
Upgrade
Impairment of Goodwill
-3.74----
Upgrade
Gain (Loss) on Sale of Investments
13.2313.163.73-0.91-0.56
Upgrade
Gain (Loss) on Sale of Assets
---51.58-
Upgrade
Asset Writedown
--4.95--8.8-
Upgrade
Pretax Income
-165.69-292.91-237.58-166.39-118.1
Upgrade
Income Tax Expense
0.18-0.6-0.47-0.30.44
Upgrade
Earnings From Continuing Operations
-165.87-292.31-237.11-166.09-118.55
Upgrade
Minority Interest in Earnings
0.030.110.317.370.71
Upgrade
Net Income
-165.84-292.19-236.81-158.73-117.84
Upgrade
Net Income to Common
-165.84-292.19-236.81-158.73-117.84
Upgrade
Shares Outstanding (Basic)
7165534328
Upgrade
Shares Outstanding (Diluted)
7165534328
Upgrade
Shares Change (YoY)
8.67%23.75%23.82%51.84%402.29%
Upgrade
EPS (Basic)
-2.33-4.47-4.48-3.72-4.19
Upgrade
EPS (Diluted)
-2.33-4.47-4.48-3.72-4.19
Upgrade
Free Cash Flow
-171.08-208.41-166.3-160.2-87.58
Upgrade
Free Cash Flow Per Share
-2.41-3.19-3.15-3.75-3.12
Upgrade
Gross Margin
100.00%----
Upgrade
Operating Margin
-278.02%----
Upgrade
Profit Margin
-245.96%----
Upgrade
Free Cash Flow Margin
-253.74%----
Upgrade
EBITDA
-186.17-247.6-225.86-207.2-118.63
Upgrade
EBITDA Margin
-276.11%----
Upgrade
D&A For EBITDA
1.291.391.430.540.16
Upgrade
EBIT
-187.46-248.99-227.29-207.74-118.79
Upgrade
EBIT Margin
-278.02%----
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q